Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2021 Results Conference Call March 22, 2022 5:00 PM ET Company Participants Susan Pietropaolo - Corporate Communications and IR Dr. William G. Rice - Chairman, President and CEO Dr. Joti Marango - SVP, CFO, and Chief Business Officer Dr. Rafael Bejar - SVP and Chief Medical Officer Conference Call Participants Ted Tenthoff - Piper Sandler Joe Pantginis - H.C. Wainwright Matt Biegler - Oppenheimer Soumit Roy - Jones Research Matthew Cross - Allegiance Global Partners ...

Aptose Biosciences Inc. (NASDAQ:APTO) Q3 2021 Earnings Conference Call November 11, 2021 5:00 PM ET Company Participants Susan Pietropaolo - Communications Representative Dr. William Rice - Chairman, President and CEO Dr. Jotin Marango - Senior Vice President, Chief Financial Officer and CBO Dr. Rafael Bejar - Senior Vice President and CMO Conference Call Participants Alethia Young - Cantor Fitzgerald Gregory Renza - RBC Capital Markets Joe Pantginis - H.C. Wainwright Matt Biegler - Oppenheimer John Newman ...

Aptose Biosciences Inc. (NASDAQ:APTO) Q2 2021 Earnings Conference Call August 3, 2021 5:00 PM ET Company Participants Susan Pietropaolo - Communications Representative William Rice - Chairman, President and Chief Executive Officer Rafael Bejar - Senior Vice President and Chief Medical Officer Jotin Marango - Senior Vice President, Chief Financial Officer and Chief Business Officer Conference Call Participants Ted Tenthoff - Piper Sandler & Co. John Newman - Canaccord Genuity Corp. Emily Bodnar - Cantor Fitz ...